ArticleCommunications biology2026

Novel CRISPR-Cas9 BAP1 knockout pre-clinical tumor model recapitulates human melanoma tumorigenesis and immune evolution.

Mona M Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.